Yufeng Ding Selected Research

OSM-LIF Receptors

1/2022	Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis.
1/2019	Phosphorylation of LIFR promotes prostate cancer progression by activating the AKT pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yufeng Ding Research Topics

Disease

7	Neoplasms (Cancer) 12/2022 - 04/2017
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2022 - 10/2021
2	Neoplasm Metastasis (Metastasis) 04/2017 - 01/2017
1	Pain (Aches) 01/2022
1	Bell Palsy (Bell's Palsy) 01/2022
1	Adenocarcinoma 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Hypokinesia (Bradykinesia) 01/2022
1	Psoriatic Arthritis 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Ankylosing Spondylitis 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Carcinoma (Carcinomatosis) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Kidney Diseases (Kidney Disease) 03/2021
1	Acute Kidney Injury (Acute Renal Failure) 03/2021
1	Hypoalbuminemia 03/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Gout 09/2020
1	Hyperuricemia 09/2020
1	Diabetes Mellitus 10/2018
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Hypersensitivity (Allergy) 11/2017
1	Disease Progression 04/2017
1	Body Weight (Weight, Body) 01/2017
1	Fetal Weight 01/2017
1	Hyperoxaluria (Oxaluria) 11/2016
1	Insulin Resistance 11/2016
1	Urinary Calculi (Urinary Calculus) 11/2016

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2021
2	Amino Acids FDA Link 12/2022 - 10/2021
2	OSM-LIF ReceptorsIBA 01/2022 - 01/2019
2	TensinsIBA 01/2019 - 04/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 04/2017
2	CorticosteroneIBA 11/2017 - 01/2017
1	Axitinib (AG 013736)IBA 04/2022
1	NivolumabIBA 01/2022
1	secukinumabIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Glutamic Acid (Glutamate)FDA Link 10/2021
1	Glutamate DehydrogenaseIBA 10/2021
1	EnzymesIBA 10/2021
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	dacomitinibIBA 10/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2021
1	CreatinineIBA 03/2021
1	Pharmaceutical PreparationsIBA 03/2021
1	camrelizumabIBA 01/2021
1	Uric Acid (Urate)IBA 09/2020
1	FYX-051IBA 09/2020
1	Xanthine DehydrogenaseIBA 09/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	2- (1- hydroxy- 4- oxocyclohexa- 2,5- dienyl)pyran- 4- oneIBA 12/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017
1	TransferasesIBA 04/2017
1	Histones (Histone)IBA 04/2017
1	Histone MethyltransferasesIBA 04/2017
1	Biological ProductsIBA 04/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 01/2017
1	SteroidsIBA 01/2017
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017
1	CholesterolIBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	steroidogenic acute regulatory proteinIBA 01/2017
1	ethyl acetateIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2016
1	Calcium OxalateIBA 11/2016

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 10/2018
3	Therapeutics 01/2022 - 01/2021
1	Punctures 01/2022